Vaxess Technologies
Dr. Fruehauf is the Co-Founder and General Partner of BioInnovation Capital. He is also a Founder and current President and Executive Director of LabCentral, a launchpad for high-potential biotech startups. Prior to LabCentral, he founded Cambridge Biolabs, a contract research facility serving startup and virtual companies in Kendall Square. Dr. Fruehauf is also a Co-Founder of ViThera Pharmaceuticals, Deltix and Cequent Pharmaceuticals, and an advisor or board member to numerous life sciences companies and non-profits.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Vaxess Technologies
Vaxess Technologies is a venture capital and Gates Foundation-backed life science company developing novel vaccine formulations and delivery technologies based on its proprietary silk platform. They are committed to improving access to vaccines by enabling better, more stable vaccine products that can be easily delivered all over the world.